This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Robert Lee Dufield: Innovator in Binding Molecules
Introduction
Robert Lee Dufield is an accomplished inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules. His work focuses on innovative solutions that have the potential to impact pharmaceutical applications.
Latest Patents
Robert Lee Dufield holds a notable patent for 4-1Bb Binding Molecules. This patent provides isolated binding molecules that specifically bind to human 4-BB. It includes nucleic acid molecules encoding an amino acid sequence of the binding molecules, vectors comprising these nucleic acid molecules, and host cells containing the vectors. Additionally, the patent outlines methods for making the binding molecules, pharmaceutical compositions containing them, and methods for using these binding molecules or compositions.
Career Highlights
Robert Lee Dufield is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to advance medical science and improve patient outcomes.
Collaborations
Throughout his career, Robert has collaborated with talented professionals in the field. Some of his notable coworkers include Bianca Ahrens and Sangita M Baxi, who contribute to the innovative environment at Pfizer.
Conclusion
Robert Lee Dufield is a prominent figure in the biotechnology sector, known for his work on binding molecules and his contributions to pharmaceutical research. His innovative spirit and collaborative efforts continue to drive advancements in the industry.